Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

A

AXSM

Axsome Therapeutics Inc

130.61

Nov 05 • 1:51 PM ET -6.39 (-4.66%)

Healthcare Biotechnology USA Mid NASD

Peers: JAZZ HRMY ACAD NBIX ALKS PRAX SUPN BHVN XENE TEVA

| Held by: VTI VB VBK VXF FBT IBB IWP SCHA IWR VHT

Scroll to Statements

Index	-
Market Cap	6.87B
Enterprise Value	6.78B
Income	-157.29M
Sales	865.27M
Book/sh	2.01
Cash/sh	5.97
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	925
IPO	Nov 19, 2015

P/E	-
Forward P/E	36.94
PEG	-
P/S	7.94
P/B	65.13
P/C	21.89
P/FCF	-
EV/EBITDA	-
EV/Sales	7.84
Quick Ratio	1.34
Current Ratio	1.42
Debt/Eq	2.13
LT Debt/Eq	1.40
Option/Short	Yes / Yes

EPS (ttm)	-3.06
EPS next Y	3.54
EPS next Q	-0.08
EPS this Y	28.74%
EPS next Y	234.85%
EPS next 5Y	-
EPS past 3/5Y	7.17% -5.89%
Sales past 3/5Y	133.68% -
EPS Y/Y TTM	34.51%
Sales Y/Y TTM	54.16%
EPS Q/Q	74.00%
Sales Q/Q	51.87%
Earnings	Nov 02 BMO
EPS/Sales Surpr.	60.59% 4.21%

Insider Own	15.65%
Insider Trans	-2.56%
Inst Own	73.57%
Inst Trans	0.42%
ROA	-21.03%
ROE	-175.59%
ROIC	-62.06%
Gross Margin	92.02%
Oper. Margin	-18.88%
Profit Margin	-18.18%
SMA20	-13.09%
SMA50	-27.08%
SMA200	-34.17%
Trades

Shs Outstand	52.58M
Shs Float	44.37M
Short Float	7.01%
Short Ratio	3.74
Short Interest	3.11M
52W High	260.19 -49.80%
52W Low	123.00 6.19%
Volatility	7.91% 4.88%
ATR (14)	8.08
RSI (14)	21.43
Beta	0.83
Rel Volume	1.02
Avg Volume	832.28K
Volume	586,943

Perf Week	-8.95%
Perf Month	-24.49%
Perf Quarter	-38.61%
Perf Half Y	-40.69%
Perf YTD	-28.49%
Perf Year	-3.74%
Perf 3Y	100.51%
Perf 5Y	224.90%
Perf 10Y	1956.85%
Recom	1.13
Target Price	265.86
Prev Close	137.00
Price	130.61
Change %	-4.66%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)